Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
F. Hurst Lin (“Lin”) AUGX Augmedix, Inc. Common Stock 13D/A 10.9% 3y
Board of Directors of MetLife, Inc., as an entity MET Metlife Inc 13D/A 16% 3y
WHITE MOUNTAINS INSURANCE GROUP LTD MAX MediaAlpha, Inc. 13D/A 48.7% 3y
Soleus Capital Master Fund, L.P. YARW Yarrow Bioscience, Inc. 13G 6.4% 3y
TPG GP A, LLC TPG TPG Inc. 13D 80.4% 3y
TPG GP A, LLC HOUS Anywhere Real Estate Inc. 13D/A 8.9% 3y
Nextech Crossover I GP S.a. r.l. AMAM Ambrx Biopharma, Inc. Common Stock 13G 5% 3y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 12.66% 3y
Advance/Newhouse Partnership CHTR Charter Communications, Inc. 13D/A 12.4% 3y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 11.78% 3y
Brookstone Capital Management BAPR Sageworth Trust Co 13G/A 6.22% 3y
Taconic Capital Advisors LP CCVI Churchill Capital Corp VI 13G/A 0% 3y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 13.8% 3y
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 13.25% 3y
Coeur Mining, Inc. ASM Avino Silver & Gold Mines Ltd 13G/A 5.4% 3y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 12.2% 3y
BCE-Mach Aggregator LLC MNR Mach Natural Resources LP 13G 71.8% 3y
MILLENNIUM MANAGEMENT LLC EBIX Ebix Inc 13G 5.2% 3y
Bay Pond Partners, L.P. CUBI Customers Bancorp, Inc. 13G 5.09% 3y
EVR Research LP SSTI Soundthinking, Inc. 13G 5.7% 3y
Deep Track Capital, LP ALGS Aligos Therapeutics, Inc. 13G 9.99% 3y
Deep Track Capital, LP AMAM Ambrx Biopharma, Inc. Common Stock 13G 5.65% 3y
VIKING GLOBAL INVESTORS LP VKTX Viking Therapeutics, Inc. 13G 5.9% 3y
Schlumberger N.V. (Schlumberger Limited) KITT Nauticus Robotics, Inc. 13D 17.4% 3y
van Kesteren Foundation JANL Janel Corp 13G 6.9% 3y
ORBIMED ADVISORS LLC APLM Apollomics Inc. 13D/A 18.1% 3y
Saba Capital Management, L.P. EMO ClearBridge Energy Midstream Opportunity Fund Inc. 13D/A 21.86% 3y
Politan Capital Management LP AZTA Azenta, Inc. 13D/A 7.61% 3y
GNI Group Ltd. GYRE Gyre Therapeutics, Inc. 13D/A 85.36% 3y
Ben M. Brigham AESI Atlas Energy Solutions Inc. 13D/A 45.1% 3y
ICAHN CARL C CCK Crown Holdings, Inc. 13D/A 6.7% 3y
Saba Capital Management, L.P. IGA Voya Global Advantage & Premium Opportunity Fund 13D 5.22% 3y
Professional Financial Advisors, LLC AADR AdvisorShares Trust 13G 10% 3y
Ruiyuan Technology Holdings Limited CCG Cheche Group Inc. 13G 5.9% 3y
Magnetar Financial LLC CCV Churchill Capital Corp V 13G/A 0% 3y
Saudi Arabian Mining Company (Ma’aden) IE Ivanhoe Electric Inc. 13D/A 9.9% 3y
SHAH CAPITAL MANAGEMENT VEON VEON Ltd. 13D/A 6.62% 3y
Bertelsmann SE & Co. KGaA AFYA Afya Ltd 13D/A 59.44% 3y
Point72 Asset Management, L.P. SNDX Syndax Pharmaceuticals Inc 13G 5.1% 3y
STILWELL JOSEPH PVBC Provident Bancorp, Inc. (MD) Common Stock 13D/A 10.4% 3y
Fernando Chico Pardo ASR Southeast Airport Group 13D/A 30.67% 3y
EIG Veteran Equity Aggregator, L.P. USAC USA Compression Partners, LP 13D/A 19.3% 3y
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 13.15% 3y
Edward Smolyansky LWAY Lifeway Foods, Inc. 13D/A 21.2% 3y
Columbus Capital Management, LLC HSDT Solana Co 13G 9.6% 3y
I.B.F Management Ltd. ADXS Advaxis, Inc. 13D/A 28% 3y
Natural Selection Fund I, LP NMPGY Navios Maritime Holdings Inc. 13D 6.57% 3y
Formidable Asset Management, LLC FLUX Flux Power Holdings, Inc. 13D 20.27% 3y
Xiang Li WNW Meiwu Technology Co Ltd 13G 7.91% 3y
Zhendong Zhang WNW Meiwu Technology Co Ltd 13G 8.55% 3y